絞り込み

16645

広告

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.

著者 Laithier V , Grill J , Le Deley MC , Ruchoux MM , Couanet D , Doz F , Pichon F , Rubie H , Frappaz D , Vannier JP , Babin-Boilletot A , Sariban E , Chastagner P , Zerah M , Raquin MA , Hartmann O , Kalifa C ,
J Clin Oncol.2003 Dec 15 ; 21(24):4572-8.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Pediatric and Adolescent Medicine, Insitut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France.

スターを付ける スターを付ける     (107view , 0users)

Full Text Sources

Miscellaneous

To evaluate a strategy aimed at avoiding radiotherapy during first-line treatment of children with progressive optic pathway tumors (OPT), by exclusively administering multiagent chemotherapy during 16 months.
PMID: 14673044 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード